- Home
- FRAF vs TLSA Comparison
FRAF vs TLSA Comparison
Compare FRAF & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- TLSA
- Stock Information
- Founded
- FRAF 1906
- TLSA 2013
- Country
- FRAF United States
- TLSA United Kingdom
- Employees
- FRAF N/A
- TLSA N/A
- Industry
- FRAF Major Banks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- FRAF Finance
- TLSA Health Care
- Exchange
- FRAF Nasdaq
- TLSA Nasdaq
- Market Cap
- FRAF 212.1M
- TLSA 187.0M
- IPO Year
- FRAF N/A
- TLSA 2000
- Fundamental
- Price
- FRAF $45.43
- TLSA $1.97
- Analyst Decision
- FRAF
- TLSA
- Analyst Count
- FRAF 0
- TLSA 0
- Target Price
- FRAF N/A
- TLSA N/A
- AVG Volume (30 Days)
- FRAF 17.1K
- TLSA 449.2K
- Earning Date
- FRAF 10-21-2025
- TLSA 05-06-2025
- Dividend Yield
- FRAF 2.91%
- TLSA N/A
- EPS Growth
- FRAF 5.82
- TLSA N/A
- EPS
- FRAF 3.29
- TLSA N/A
- Revenue
- FRAF $74,998,000.00
- TLSA N/A
- Revenue This Year
- FRAF N/A
- TLSA N/A
- Revenue Next Year
- FRAF N/A
- TLSA N/A
- P/E Ratio
- FRAF $13.81
- TLSA N/A
- Revenue Growth
- FRAF 8.15
- TLSA N/A
- 52 Week Low
- FRAF $28.01
- TLSA $0.63
- 52 Week High
- FRAF $49.42
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- FRAF 41.37
- TLSA 53.23
- Support Level
- FRAF $44.90
- TLSA $1.90
- Resistance Level
- FRAF $48.60
- TLSA $2.18
- Average True Range (ATR)
- FRAF 0.69
- TLSA 0.17
- MACD
- FRAF -0.59
- TLSA 0.02
- Stochastic Oscillator
- FRAF 11.73
- TLSA 46.48
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.